Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year

An executive at Adaptive Biotechnologies reported the sale of 179,703 shares for about $2.37 million, based on a weighted average price of around $13.21 per share during March 11–13, 2026. This sale was executed directly and arose from the exercise and immediate sale of option-derived Common Stock; no indirect (e.g.